Depression

Impaired Mood Homeostasis Linked With Depression
People with low mood and a history of depression tend not to use mood-modifying activities to stabilize mood, according to research published online in JAMA Psychiatry.
Depressive Disorders ‘Vastly Underdiagnosed’ in People With HIV/AIDS
Depression is “vastly underdiagnosed” in people with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), states a literature review published online in the Harvard Review of Psychiatry.
Study Suggests Novel Target for New Antidepressants
The protein GPR56 may provide an easy-to-measure biomarker of a patient’s response to antidepressants as well as a novel drug target for the treatment of major depressive disorder, according to a published study.
Using Antipsychotics as an Adjunctive Therapy in Depression
Michael Thase, MD, of the University of Pennsylvania, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
Pregnancy Depression Associated With Lower Immunity in Infants
Women who had depressive symptoms during their third trimester of pregnancy, or persistently before and after giving birth, were twice as likely to have babies with very low levels of immunoglobulin A.
Quiz: Which Antidepressant Is Used in AXS-05?
AXS-05, which significantly improved symptoms of depression in a recent phase 3 trial, combines dextromethorphan and which antidepressant?
Combining Antidepressants When Treating Depression
Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.
Novel Dextromethorphan-Bupropion Tablet Rapidly Improves Depressive Symptoms
AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.
Cannabinoids Not Justified as Mental Health Treatment, Study Says
A meta-analysis recently published in The Lancet Psychiatry found that using medicinal cannabinoids to treat mental health disorders cannot be justified, due to a lack of evidence of effectiveness and known risks of the substances.
Teen Depression Risk Lower in Close-Knit Families
Teens with positive family relationships may be less likely to develop depression during adolescence or early adulthood, a new study suggests.
Oral Contraceptives Linked to Depressive Symptoms in Teens
Teenage users of oral contraceptive pills (OCP), particularly 16-year-olds, had higher concurrent depressive symptoms than their nonuser peers in an observational study.

Audio

ABC News Podcast Features Psych Congress Faculty
Two members of the Psych Congress Steering Committee have been featured on an ABC News podcast which grew out of a newsman's newfound interest in meditation.
A Discussion on the Science of Depression
Listen as Psych Congress Steering Committee member Charles Raison, MD, discusses a book he coauthored, The New Mind-Body Science of Depression, with David Van Nuys, PhD, on Shrink Rap Radio.
Back to Top